Hong Kong-listed Meituan disclosed that on 15 July 2026 it granted a total of 13.51 million restricted share units (RSUs) under its Post-IPO Share Award Scheme.

Of the allocation, 13.42 million RSUs were awarded to employees across the Group, while 47,045 RSUs each were awarded to independent non-executive directors Ms. Yang Marjorie Mun Tak and Mr. Yiu Kin Wah Stephen.

The awards carry no purchase price and reference a market price of HK$83.40 per Class B share on the grant date. Employee RSUs will vest over 20–47 months, with the first tranche vesting within 12 months. The directors’ RSUs will vest quarterly over 35 months, with 8.33% released each quarter from 30 September 2026 to 30 June 2029. All RSUs follow a purely time-based schedule and contain no performance targets.

A claw-back mechanism applies: unvested RSUs lapse, and vested shares or proceeds can be reclaimed if a grantee is convicted of a criminal offence, breaches covenants or triggers other prescribed events.

The Board stated the grant aligns management and employee interests with shareholders and supports talent retention. The independent non-executive director grants comply with Hong Kong Listing Rules, remaining within the 0.1% share issuance cap for such directors.

After the transaction, 349.26 million underlying shares remain available for future awards under the overall Scheme Limit, with 62.12 million shares still available under the Service Provider Sublimit. All RSUs are expected to be settled through the issue of new Class B shares or transfer of treasury shares.